Emergent BioSolutions Inc.’s U.S. Health and Human Services contract to help produce flu vaccines in the event of a pandemic are key to the firm’s expansion, Chief Financial Officer Robert G. Kramer says.

The Baltimore Development Corp. on Wednesday confirmed that it is offering a second $250,000 new job creation tax incentive to Emergent.